EYES Market Cap History
Below is a table of the EYES market cap history going back to 3/13/2015:

Date EYES Market Cap

Also see: EYES Shares Outstanding History
and EYES YTD Return
EYES Historical Market Cap:
-44.33% CAGR
EYES Historical Market Cap: +-44.33% CAGR

Mouse over chart for data details
3/13/2015 ...8/10/2020
Second Sight Medical Products develops, manufactures and markets implantable visual prosthetics that deliver artificial vision to blind individuals. Co.'s product, the Argus ® II Retinal Prosthesis System (Argus II), treats outer retinal degenerations, such as retinitis pigmentosa, also referred to as RP. RP is a hereditary disease that causes a progressive degeneration of the light-sensitive cells of the retina, which leads to visual impairment and blindness. The Argus II System provides an artificial form of vision that differs from the vision of people with normal sight. It does not restore normal vision nor slow the progression of the disease. We show 26 historical shares outstanding datapoints in our EYES shares outstanding history coverage, used to compute EYES market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing EYES market cap history over the course of time is important for investors interested in comparing EYES's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of EYES versus a peer is one thing; comparing EYES market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like EYES can fluctuate over the course of history. With this page we aim to empower investors researching EYES by allowing them to research the EYES market cap history.
Quotes delayed 20 minutes
Get Free SEC filing alerts for EYES:
EYES SEC Filing Email Alerts ServiceExternal link
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Second Sight Medical Products (EYES) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

FATE Market Cap History
FCRE Market Cap History
FCSC Market Cap History
FGEN Market Cap History
FLDM Market Cap History
FLGT Market Cap History
FLKS Market Cap History
FLXN Market Cap History
FMI Market Cap History
FOLD Market Cap History
More Healthcare companies »


EYES Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2020, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.